Uploaded December 2024 | Updated November 2026, 3 hours ago
At the 2024 RNDS, this panel of community members discussed the benefits of setting boundaries while travelling and with colleagues, family members, and friends [00:00:10]. Rebecca Salky shared her journey on learning to say "no" and prioritizing her rest [00:01:12]. Philip Rive highlighted the challenges of accepting limited capacities and focusing on quality over quantity [00:03:24]. Leah Campbell emphasized the importance of time management and clear communication about invisible disabilities [00:06:45]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
00:00 Introduction to Community Perspectives
00:24 The Importance of Setting Boundaries
01:00 Personal Experiences with Boundaries
03:13 Invisible Disabilities and Communication Challenges
07:10 Navigating Work with Health Conditions
11:56 Adapting to Changes and Finding Balance
16:34 Travel Challenges and Solutions
23:18 Living Life to the Fullest Despite Limitations
25:18 Conclusion and Final Thoughts
At the 2024 RNDS, this panel of community members discussed the benefits of setting boundaries while travelling and with colleagues, family members, and friends [00:00:10]. Rebecca Salky shared her journey on learning to say "no" and prioritizing her rest [00:01:12]. Philip Rive highlighted the challenges of accepting limited capacities and focusing on quality over quantity [00:03:24]. Leah Campbell emphasized the importance of time management and clear communication about invisible disabilities [00:06:45]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
00:00 Introduction to Community Perspectives
00:24 The Importance of Setting Boundaries
01:00 Personal Experiences with Boundaries
03:13 Invisible Disabilities and Communication Challenges
07:10 Navigating Work with Health Conditions
11:56 Adapting to Changes and Finding Balance
16:34 Travel Challenges and Solutions
23:18 Living Life to the Fullest Despite Limitations
25:18 Conclusion and Final Thoughts
![2026 RNDS | TIMELY-PLEX Study
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), John J. Chen, MD, PhD, of Mayo Clinic, speaking remotely from Minnesota, described TIMELY-PLEX, a trial testing whether plasma exchange (PLEX) improves recovery after severe optic neuritis or myelitis [00:00:05]. He reviewed standard treatment with high-dose IV steroids, what PLEX involves, and why earlier studies of PLEX may look better than they are [00:01:10]. He explained the design: everyone receives steroids, and people are randomized to PLEX right away or to PLEX only if they have not recovered after 7 to 14 days, with almost 400 people at more than 30 US centers [00:05:52]. Dr. Chen covered who can join, including adults within 14 days of symptom onset, and the outcomes measured [00:07:57]. Michael Levy read questions on timing with steroids, MRI confirmation, telling a stroke from inflammation, and results by disease type [00:17:26].
John J. Chen, MD, PhD, is a neuro-ophthalmologist and Professor of Ophthalmology and Neurology at Mayo Clinic. He provides care for people with visual disorders related to neurological causes and works closely with neurology, rheumatology, and neurosurgery. Dr. Chen completed his MD and PhD at the University of Virginia and his ophthalmology residency and neuro-ophthalmology fellowship at the University of Iowa before joining Mayo Clinic in 2014. His clinical and research focus includes optic neuritis (MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), and multiple sclerosis), idiopathic intracranial hypertension, and neuro-ophthalmic imaging. He serves as Neuro-Ophthalmology Fellowship Director and is co-lead investigator of the TIMELY-PLEX trial, a PCORI-funded multicenter clinical trial of plasma exchange for acute optic neuritis across more than 30 US sites. He is an Associate Editor for Ophthalmology and the Journal of Neuro-Ophthalmology and has published more than 300 peer-reviewed articles.
Dr. Chen serves as Vice President of the North American Neuro-Ophthalmology Society (NANOS) and previously served as President of the Minnesota Academy of Ophthalmology and Chair of the Upper Midwest Neuro-Ophthalmology Group. He is a member of the American Ophthalmological Society and the American Eye Study Club and serves as an Oral Board Examiner for the American Board of Ophthalmology. His awards include the AAO Senior Achievement Award, the Real World Ophthalmology Inspiring Academic Leader Award, four-time Mayo Clinic Ophthalmology Teacher of the Year leading to induction into the Educators Hall of Fame, and the Mayo Clinic Distinguished Educator Award.
00:00 Introduction to TIMELY-PLEX
01:10 Standard Treatment and PLEX
03:16 Why Earlier Studies Can Mislead
05:24 How the Trial Is Designed
07:57 Who Can Join
08:56 Vision and Spinal Cord Criteria
11:56 Masked Evaluators and Safety
12:54 Outcomes That Matter
14:02 How to Refer Someone
15:06 Take-Home Messages
17:26 Audience Questions
22:21 Results by Disease Type and Closing 2026 RNDS | TIMELY-PLEX Study](https://i.ytimg.com/vi/FJ84Xjk6IeI/mqdefault.jpg)

![2026 RNDS | Getting Back to Work
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Janelle Hewelt, a certified rehabilitation counselor, spoke about returning to work after acquiring a disability [00:00:05]. She explained why returning to work supports well-being, noted that many barriers come from the environment rather than the diagnosis, and walked through the rehabilitation hierarchy of services, from the same job with accommodations to retraining [00:01:17]. Ms. Hewelt described reasonable accommodations under Title I of the Americans with Disabilities Act, the Job Accommodation Network, and common solutions such as flexible schedules, telework, dress code changes, and built-in technology [00:05:20]. She explained state vocational rehabilitation services, which can include career counseling, retraining, assistive technology, and vehicle modifications [00:10:02]. She also covered 2026 Social Security Disability Insurance rules, including trial work months, earnings thresholds, and expedited reinstatement, and shared resources, including some for veterans [00:13:30].
Janelle Hewelt is a certified rehabilitation counselor who works for the U.S. Department of Veterans Affairs as a national trainer for vocational rehabilitation counselors. She lives in Georgetown, Texas, and is also part of the SRNA community: she shared her own diagnostic story on the 2026 RNDS community panel.
00:00 Welcome and Introduction
01:17 Why Returning to Work Matters
01:43 Barriers to Returning to Work
03:28 Rehabilitation Hierarchy of Services
05:20 Reasonable Accommodations and the ADA
06:14 Job Accommodation Network
07:24 Common Accommodations
10:02 State Vocational Rehabilitation
13:30 Social Security Disability Insurance
16:49 Resources and Closing 2026 RNDS | Getting Back to Work](https://i.ytimg.com/vi/Gdb-IsjPzTA/mqdefault.jpg)



![2026 RNDS | Sexual Dysfunction and Intimacy
This episode contains adult language and content. It is not suitable for anyone under the age of 18. In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Philippines Cabahug, MD, of Kennedy Krieger Institute spoke about sexual health and intimacy after a neuroimmune disease, explaining how changes in the brain and spinal cord affect mental arousal, touch arousal, orgasm, and fertility [00:01:16]. Dr. Cabahug reviewed treatment options for men, including oral medications, injections, vacuum pumps, and penile prostheses, the more limited options for women, such as lubricant, and why autonomic dysreflexia and pregnancy safety matter [00:06:14]. She described practical strategies, including scheduling, preparing bladder and bowel routines, checking skin, positioning around spasticity, and finding new areas of sensation [00:13:47]. Dr. Cabahug closed with partner communication, changing roles when a partner becomes a care partner, the value of occupational therapists trained in sexual rehabilitation, and resources for further reading [00:17:45].
Philippines Cabahug, MD, earned her B.S. in physical therapy at the University of the Philippines in 1994 and her medical degree at St. Lukes-WHQ Memorial, Philippines, in 2000. She completed a physical medicine and rehabilitation (PM&R) residency at the Philippine General Hospital in 2005, finished an internship in internal medicine at Atlanticare Regional Medical Center in Atlantic City, New Jersey, in 2009, and completed a second PM&R residency in 2012 at Johns Hopkins Hospital, followed by a fellowship in spinal cord injury medicine at Johns Hopkins Hospital/Kennedy Krieger Institute in 2013. She then joined the International Center for Spinal Cord Injury as a full-time physician, is board certified in PM&R and in spinal cord injury medicine, and is the director of Musculoskeletal Ultrasound at Kennedy Krieger Institute.
00:00 Welcome and Session Goals
01:16 Brain and Body Disconnect
03:05 Mental and Touch Arousal
05:51 Fertility and Pregnancy
06:14 Treatment Options Overview
07:08 Autonomic Dysreflexia and Safety
08:33 Options for Men
11:45 Options for Women
13:47 Planning and Practical Strategies
15:13 Touch, Positioning, and Devices
17:45 Partner Communication and Changing Roles
19:08 Care Team, Resources, and Closing 2026 RNDS | Sexual Dysfunction and Intimacy](https://i.ytimg.com/vi/HAy_-49OlAY/mqdefault.jpg)
![2024 RNDS | A Conversation: How Do I Identify a Relapse?
At the 2024 RNDS, Rebecca Salky, RN shared her journey of living with MOG antibody disease (MOGAD) from childhood to adulthood and the numerous relapses she experienced [00:00:00]. Dr. Cynthia Wang discussed the complexities of diagnosing and treating relapses, using a fire analogy to illustrate her points [00:02:34]. Audience members shared their personal experiences and challenges with managing symptoms, emphasizing the need for better communication and support among doctors [00:10:15]. Rebecca and Dr. Wang provided practical tips for patients on how to handle relapses and pseudo-relapses, and the importance of seeking comprehensive care [00:18:59]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
00:00 Introduction and Personal Story
00:43 Understanding Relapses: Dr. Wangs Perspective
01:25 Fire Analogy: Explaining Relapse and Treatment
03:32 Personalizing Treatment and Recognizing Symptoms
05:59 Challenges in Diagnosis and Treatment
10:15 Patient Experiences and Questions
16:59 Community Support and Future Improvements
18:59 Emergency Strategies and Final Advice 2024 RNDS | A Conversation: How Do I Identify a Relapse?](https://i.ytimg.com/vi/HJADluTdy1E/mqdefault.jpg)
![1302. Pelvic Floor Therapy for Bladder and Bowel Management
Krissy Dilger of SRNA moderated this Ask the Expert episode, “Pelvic Floor Therapy for Bladder and Bowel Management,” featuring Jessica Ekberg, a certified pelvic floor therapist. Jessica explained the various conditions treated by pelvic floor therapy, emphasizing the importance of posture and breathing [00:01:05]. She discussed how pelvic floor therapy is adapted for individuals with rare neuroimmune disorders [00:04:59]. The discussion included both physical exercises and emotional work integral to the therapy [00:07:42]. Practical tips for seeking pelvic floor therapy and insurance considerations were also covered [00:10:42]. The episode concluded with encouragement to explore this underutilized service [00:19:23].
00:00 Introduction
02:03 Understanding Pelvic Floor Therapy
04:59 Pelvic Floor Therapy for Rare Neuroimmune Disorders
07:42 The Emotional and Mental Aspects of Pelvic Floor Therapy
10:42 Practical Insights and Patient Experiences
19:23 Getting Started with Pelvic Floor Therapy
27:38 Conclusion
Jessica Ekberg, OTR/L is a business owner, avid runner, former pants peer, prolapse owner, postpartum pain sufferer, mom of two, and certified pelvic floor therapist. Jessica is extremely passionate about helping men and women be the best version of themselves they can. Her goal is to bring Pelvic Floor Health discussions to the forefront of what she does, to help dispel myths and educate about facts. The lack of information and effective treatment in the community can leave people suffering in silence. Now that she has been working in pelvic health for almost five years, she realizes just how critical pelvic health is to all of us. She started her pelvic health journey after experiencing “a lot of problems” when returning to running post baby.
Jessica’s advice is to stop ignoring or putting off taking care of yourself. The core makes up the foundation of the body and if it is not functioning properly, it can impact several systems within the body. Some of the problems that clients present with are incontinence, hernias, pelvic pain including hips/back/genital/rectal/tailbone, respiratory difficulties, heavy/painful periods, menopause, endometriosis, pre/during/postpartum care, constipation, and sexual (including erectile) dysfunction. Jessica’s approach involves assessing the whole body, putting the puzzle together in order to determine the driver of the dysfunction and then developing a treatment plan to solve the problem. Her goal is to help clients return to doing all of the things they love, as quickly and safely as possible. 1302. Pelvic Floor Therapy for Bladder and Bowel Management](https://i.ytimg.com/vi/HgN1enJqJ2E/mqdefault.jpg)
![ABCs of NMOSD 702. CAR-T in NMOSD
Dr. GG deFiebre of SRNA spoke with Dr. Michael Levy and Dr. Benjamin Greenberg about CAR-T therapy for aquaporin-4-positive NMOSD.
They described why targeting B cells may reduce aquaporin-4 antibodies over time and could enable long-term remission or reduced need for ongoing drugs [01:37]. The physicians outlined an autologous Phase 1 study at Mass General and UT Southwestern [07:02]. They discussed eligibility rationale, key risks such as infection, cytokine release syndrome and ICANS, and how lessons from this NMOSD-focused trial could inform future neuroimmune disorder research [09:10]. You can find more information about the trial here:
https://clinicaltrials.gov/study/NCT07573332?cond=NMOSD&intr=CAR-T&viewType=Card&rank=1
Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program] at Children’s Medical Center.
Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago’s Rush Presbyterian-St. Luke’s Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor’s degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation’s first dedicated Transverse Myelitis Center.
Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children’s Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.
Michael Levy, MD, PhD is a recognized neurologist with over 15 years of clinical and research expertise in rare neuroimmunological disorders. He established the Neuroimmunology Clinic and Research Laboratory at Massachusetts General Hospital and is the Research Director in the Division of Neuroimmunology and Neuroinfectious Disease. Previously, Dr. Levy was on the faculty at Johns Hopkins University and was the founding Director of their Neuromyelitis Optica Clinic.
Clinically, Dr. Levy cares for patients with MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), and idiopathic transverse myelitis (TM). Dr. Levy is also the principal investigator (PI) on numerous patient studies and drug trials for new and improved treatments for these disorders. In 2022, Dr. Levy became the lead principal investigator for the two worldwide clinical trials in MOG antibody disease.
In the lab, Dr. Levy’s research focuses on the development of animal models of NMO and MOG with the goal of tolerization as a sustainable long-term treatment. Dr. Levy has more than 200 peer-reviewed research articles, reviews and editorials, and 3 patents covering NMO tolerization therapy, TM diagnostics, and stem cell regeneration approaches.
00:00 Welcome and Guests
01:37 CAR-T Explained Simply
03:27 Immune Reset vs Suppression
04:37 Why Target aquaporin-4-positive NMOSD
06:05 One-Time Remission Goal
07:02 Trial Overview and Patient Journey
09:10 Eligibility and Medication Rules
11:20 Conditioning Chemo Purpose
13:02 Safety Risks and Monitoring
16:30 Why Criteria Are Strict
20:24 How to Join the Study
22:58 Future Questions and Wrap-Up ABCs of NMOSD 702. CAR-T in NMOSD](https://i.ytimg.com/vi/HlAlJl97NQ0/mqdefault.jpg)
